Xenon Pharmaceuticals Inc. SEC filings XENE
Xenon Pharmaceuticals Inc. has 800 filings in SEC EDGAR's recent list, going back to Aug 16, 2013. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Nov 3, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 8, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 11, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 11, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 6, 2020 | Jun 30, 2020 |
| 10-Q/A | Amended quarterly report | May 26, 2020 | Mar 31, 2020 |
| 10-Q/A | Amended quarterly report | May 22, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | May 21, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Nov 5, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 6, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | May 7, 2019 | Mar 31, 2019 |
| 10-Q | Quarterly report | Nov 6, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Aug 7, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | May 8, 2018 | Mar 31, 2018 |
| 10-Q | Quarterly report | Nov 7, 2017 | Sep 30, 2017 |
| 10-Q | Quarterly report | Aug 3, 2017 | Jun 30, 2017 |
| 10-Q | Quarterly report | May 9, 2017 | Mar 31, 2017 |
| 10-Q | Quarterly report | Nov 3, 2016 | Sep 30, 2016 |
| 10-Q | Quarterly report | Aug 3, 2016 | Jun 30, 2016 |
| 10-Q | Quarterly report | May 10, 2016 | Mar 31, 2016 |
| 10-Q | Quarterly report | Nov 10, 2015 | Sep 30, 2015 |
| 10-Q | Quarterly report | Aug 13, 2015 | Jun 30, 2015 |
| 10-Q/A | Amended quarterly report | Aug 13, 2015 | Mar 31, 2015 |
| 10-Q | Quarterly report | May 12, 2015 | Mar 31, 2015 |
| 10-Q | Quarterly report | Dec 15, 2014 | Sep 30, 2014 |
Showing 39 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- XENE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Burnaby
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1582313
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.